Anti-plasma cell treatment in refractory autoimmune hemolytic anemia in a child with multivisceral transplant.

Shahira Ghobrial Corina Elena Gonzalez Stuart S KaufmanNada YazigiCal MatsumotoThomas FishbeinJason HawksworthUdeme D EkongAlexander KroemerKhalid Khan

Published in: Pediatric transplantation (2021)

We propose early targeted anti-plasma cell therapy with steroid burst, IVIG, rituximab, and possible plasmapheresis may reduce morbidity in secondary refractory w-AIHA.

Keyphrases

cell therapy
stem cells
mesenchymal stem cells
diffuse large b cell lymphoma
mental health
chronic kidney disease
multiple sclerosis
single cell
high frequency
replacement therapy
smoking cessation